4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-17-020055
10% owner sold 21,132 shares at an average $13.91 ($293,843)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Atlas Venture Associates IX, L.P. 10% owner | 2017-03-09 | Sale | −15,628 | $13.85 | $216,432 | 5,504 | D: show line 1 in the form |
| Atlas Venture Associates IX, L.P. 10% owner | 2017-03-10 | Sale | −5,504 | $14.06 | $77,410 | 0 | D: show line 2 in the form |
| Open-market sales · 21,132 sh · avg $13.91 · $293,843 | |||||||
Loading xslF345X03/doc4.xml…